1. Review of rituximab in primary CNS lymphoma
   Pawan K. Singh et al, 2020, Journal of the Neurological Sciences CrossRef
2. Management of primary central nervous system lymphoma
   Louis Royer-Perron et al, 2018, La Presse Médicale CrossRef
3. Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
   Przemysław Koźmiński et al, 2020, International Journal of Molecular Sciences CrossRef
4. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL
   Michele Da Broi et al, 2018, Blood Cells, Molecules, and Diseases CrossRef
5. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
   Xuefei Sun et al, 2017, Oncotarget CrossRef
6. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre
   Huafeng Wang et al, 2018, Journal of International Medical Research CrossRef
7. Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
   Ni Fan et al, 2017, Oncotarget CrossRef
8. Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition
   Eric A Severson et al, 2023, The Oncologist CrossRef
9. Case series on patients with primary central nervous system lymphoma: From clinical presentations to outcomes
   Kazem Anvari et al, 2022, Clinical Case Reports CrossRef
10. Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL)
    Yasuji Miyakita et al, 2017, Japanese Journal of Clinical Oncology CrossRef
11. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies
    Tarsheen K. Sethi et al, 2019, Leukemia & Lymphoma CrossRef
12. Advances and challenges in the treatment of primary central nervous system lymphoma
    Hua Yang et al, 2020, Journal of Cellular Physiology CrossRef
13. Primary central nervous system lymphoma with no enhancement initially and no significant progression over a long term: a case report and review of the literature
    Ning-ning Hu et al, 2019, International Journal of Neuroscience CrossRef
14. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
    Torstein R. Meling et al, 2018, Neuroradiology CrossRef